These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 9686602)
1. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. Ragg SJ; Kaga S; Berg KA; Ochi A J Immunol; 1998 Aug; 161(3):1390-8. PubMed ID: 9686602 [TBL] [Abstract][Full Text] [Related]
2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Miranda MB; McGuire TF; Johnson DE Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350 [TBL] [Abstract][Full Text] [Related]
3. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
6. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Franklin CC; Kraft AS Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188 [TBL] [Abstract][Full Text] [Related]
7. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein. Biggs JR; Ahn NG; Kraft AS Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183 [TBL] [Abstract][Full Text] [Related]
8. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937). Vrana JA; Saunders AM; Chellappan SP; Grant S Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391 [TBL] [Abstract][Full Text] [Related]
9. The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle. Pyne S; Pyne NJ Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):917-23. PubMed ID: 8645177 [TBL] [Abstract][Full Text] [Related]
10. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Jarvis WD; Fornari FA; Auer KL; Freemerman AJ; Szabo E; Birrer MJ; Johnson CR; Barbour SE; Dent P; Grant S Mol Pharmacol; 1997 Dec; 52(6):935-47. PubMed ID: 9415703 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Pumiglia KM; Decker SJ Proc Natl Acad Sci U S A; 1997 Jan; 94(2):448-52. PubMed ID: 9012803 [TBL] [Abstract][Full Text] [Related]
12. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells. Ohmori M; Shirasawa S; Furuse M; Okumura K; Sasazuki T Cancer Res; 1997 Nov; 57(21):4714-7. PubMed ID: 9354428 [TBL] [Abstract][Full Text] [Related]
13. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589 [TBL] [Abstract][Full Text] [Related]
14. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line. Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288 [TBL] [Abstract][Full Text] [Related]
15. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Herrera R; Hubbell S; Decker S; Petruzzelli L Exp Cell Res; 1998 Feb; 238(2):407-14. PubMed ID: 9473349 [TBL] [Abstract][Full Text] [Related]
16. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells. Conway A; Pyne NJ; Pyne S Cell Signal; 2000 Dec; 12(11-12):737-43. PubMed ID: 11152959 [TBL] [Abstract][Full Text] [Related]
17. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. Medvedev AE; Blanco JC; Qureshi N; Vogel SN J Biol Chem; 1999 Apr; 274(14):9342-50. PubMed ID: 10092612 [TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter. Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. Tamir A; Granot Y; Isakov N J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733 [TBL] [Abstract][Full Text] [Related]
20. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Hartkamp J; Troppmair J; Rapp UR Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]